3 Lending Software Company, Healthcare Technology and Services Firm and IT Services Provider Stocks With a Strong Future Roadmap: Nucleus Software Exports, Inventurus Knowledge Solutions and Mindteck (India)
- October 30, 2026
- Posted by: Harsh Piplani
- Category: Best Stocks
Nucleus Software Exports, Inventurus Knowledge Solutions and Mindteck (India): ROE of 10.4% to 25.8% and FY22 to FY26 revenue CAGR of 8.3% to 42.2%. Prices as of 29 Oct 2026.
Quick Answer
The three lending software, health services and IT stocks to watch are Nucleus Software Exports, Inventurus Knowledge Solutions and Mindteck (India). Their return on equity ranges from 10.4% to 25.8%, and their revenue compound annual growth from FY22 to FY26 ranges from 8.3% to 42.2%. Inventurus Knowledge Solutions leads on both return on equity at 25.8% and revenue growth at 42.2% a year. Prices are based on the 29 October 2026 close, and this article is educational, not investment advice.
Lending software, health services and IT stocks let investors follow companies that serve a growing part of the Indian economy. Nucleus Software Exports, Inventurus Knowledge Solutions and Mindteck (India) cover a lending and transaction banking software company, a healthcare technology and services firm and an IT services provider.
This list covers three lending software, health services and IT stocks with complete current figures: Nucleus Software Exports, Inventurus Knowledge Solutions and Mindteck (India). Every figure comes from the latest reported financials and the 29 October 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are Lending Software, Health Services and IT Stocks?
Lending software, health services and IT stocks are listed companies that sell lending and transaction banking software, support healthcare providers and payors with technology and services and deliver software, data and cloud work to clients in healthcare and finance. Their earnings depend on product licences, contracts and client budgets.
Lending Software, Health Services and IT Stocks at a Glance
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE (%) | D/E |
|---|---|---|---|---|---|---|
| Nucleus Software Exports | 661.05 | 1,731 | 16.4 | 17.5 | 14.7 | 0.01 |
| Inventurus Knowledge Solutions | 1,710.9 | 29,242 | 38.3 | 17.6 | 25.8 | 0.27 |
| Mindteck (India) | 135.22 | 436 | 14.0 | 17.6 | 10.4 | 0.01 |
On valuation, Nucleus Software Exports and Mindteck (India) trade at a P/E below the industry P/E, while Inventurus Knowledge Solutions trades above it, which reflects the growth the market already expects. Readers comparing lending software, health services and IT stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain.
Why Do Lending Software, Health Services and IT Stocks Have a Strong Roadmap in India?
Lending software, health services and IT stocks have a strong roadmap in India because banks upgrading their systems, healthcare organisations adopting digital tools and wider use of data and cloud keep widening the market for these technology companies.
- Bank systems. Lenders replace older platforms.
- Healthcare data. Providers adopt digital and AI tools.
- Cloud work. Clients move more work to platforms.
Why Nucleus Software Exports Features Among These Lending Software, Health Services and IT Stocks
Among the lending software, health services and IT stocks on this list, Nucleus Software Exports is a Noida-based software products company that builds lending and transaction banking software, with its FinnAxia and FinnOne platforms used by banks and financial institutions in India and overseas.
The company has a return on equity of 14.7%, a debt to equity ratio of 0.01 and a market capitalisation of Rs 1,731 crore. The stock trades at a P/E of 16.4, below the industry P/E of 17.5.
Revenue rose from Rs 532 crore in FY22 to Rs 940 crore in FY26, a compound annual growth rate of 15.3%. Net profit grew from Rs 40.9 crore in FY22 to Rs 117 crore in FY26, which works out to a compound annual growth rate of 30.0%.
Roadmap: The company is moving customers to cloud-based and subscription offerings, which build recurring revenue over time. Banks upgrading lending and transaction systems create steady demand for its platforms.
What to watch: Monitor licence and subscription revenue and the pace of new customer wins.
Why Inventurus Knowledge Solutions Features Among These Lending Software, Health Services and IT Stocks
Among the fintech and health services shares on this list, Inventurus Knowledge Solutions, known as IKS, is a Mumbai-based healthcare technology and services company that supports healthcare providers and payors in the United States with analytics, clinical coding and technology platforms.
Revenue rose from Rs 784 crore in FY22 to Rs 3,211 crore in FY26, a compound annual growth rate of 42.2%. Net profit grew from Rs 233 crore in FY22 to Rs 722 crore in FY26, which works out to a compound annual growth rate of 32.7%.
In the June 2026 quarter, revenue grew 21.0% year on year to Rs 899 crore, while net profit rose 27.8% to Rs 194 crore. The company has a return on equity of 25.8%, a debt to equity ratio of 0.27 and a market capitalisation of Rs 29,242 crore. The stock trades at a P/E of 38.3, above the industry P/E of 17.6.
Roadmap: The company is widening its technology-led services for risk adjustment, care coordination and revenue cycle work. Long-term relationships with large healthcare organisations give it recurring demand.
What to watch: Follow client additions, platform adoption and healthcare policy changes in the United States.
Why Mindteck (India) Features Among These Lending Software, Health Services and IT Stocks
Among the three companies on this list, Mindteck (India) provides IT services including software development, data and analytics and cloud support to clients across healthcare, financial services and other industries.
In the June 2026 quarter, revenue grew 2.8% year on year to Rs 107 crore. Revenue rose from Rs 304 crore in FY22 to Rs 417 crore in FY26, a compound annual growth rate of 8.3%.
Net profit grew from Rs 20.8 crore in FY23 to Rs 31.5 crore in FY26, which works out to a compound annual growth rate of 14.9%. The company has a return on equity of 10.4%, a debt to equity ratio of 0.01 and a market capitalisation of Rs 436 crore. The stock trades at a P/E of 14.0, below the industry P/E of 17.6.
Roadmap: The company is focusing on digital engineering, data and cloud services for existing clients and widening its work in specialised industries. Long client relationships support steady project flow.
What to watch: Monitor client additions, utilisation and currency movements.
Nucleus Software Exports vs Inventurus Knowledge Solutions vs Mindteck (India) on Key Financials
The table below sets the three lending software, health services and IT stocks side by side on revenue, profit and margin, using reported figures.
| Company | FY22 Revenue (Rs Cr) | FY26 Revenue (Rs Cr) | Revenue CAGR (FY22-FY26) | FY26 Net Profit (Rs Cr) | FY26 Net Margin |
|---|---|---|---|---|---|
| Nucleus Software Exports | 532 | 940 | 15.3% | 117 | 12.4% |
| Inventurus Knowledge Solutions | 784 | 3,211 | 42.2% | 722 | 22.5% |
| Mindteck (India) | 304 | 417 | 8.3% | 31.5 | 7.6% |
Inventurus Knowledge Solutions posts the highest return on equity in this group at 25.8%. Inventurus Knowledge Solutions combines the largest FY26 revenue at Rs 3,211 crore with the fastest revenue growth, a 42.2% compound annual rate. A useful habit with lending software, health services and IT stocks is to check each new quarterly result against the capacity plans the company described earlier.
Key Risks to Check Before Investing in Lending Software, Health Services and IT Stocks
Every theme carries risks that deserve a check before any decision. For these lending software, health services and IT stocks, the main points are: Long-term fintech and health services shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.
- Client spending. Technology budgets can vary with global conditions.
- Currency moves. Export earnings move with the rupee.
- Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them.
Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.
Use the Univest Stock Screener to filter lending software, health services and IT stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.
Final Thoughts on Lending Software, Health Services and IT Stocks
Lending software, health services and IT stocks reward investors who follow demand trends, order books and margins together. Nucleus Software Exports, Inventurus Knowledge Solutions and Mindteck (India) each have a clear plan to grow. Based on the 29 October 2026 close, Nucleus Software Exports trades at Rs 661.05, Inventurus Knowledge Solutions at Rs 1,710.9 and Mindteck (India) at Rs 135.22. Valuation matters as much as growth, so compare each company’s P/E with its industry P/E before adding any of these lending software, health services and IT stocks to a watchlist.
Download the Univest iOS App or Univest Android App to track lending software, health services and IT stocks, set price alerts and get research-backed stock ideas.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
What are lending software, health services and IT stocks?
Ans. Lending software, health services and IT stocks are listed companies that sell lending and transaction banking software, support healthcare providers and payors with technology and services and deliver software, data and cloud work to clients in healthcare and finance. Their earnings depend on product licences, contracts and client budgets. This list looks at three of them, Nucleus Software Exports, Inventurus Knowledge Solutions and Mindteck (India), using reported FY22 to FY26 financials and the 29 October 2026 closing prices.
Which lending software, health services and IT stocks are covered in this list?
Ans. This list covers Nucleus Software Exports, Inventurus Knowledge Solutions and Mindteck (India). Based on the 29 October 2026 close, Nucleus Software Exports traded at Rs 661.05, Inventurus Knowledge Solutions at Rs 1,710.9 and Mindteck (India) at Rs 135.22. Their return on equity ranges from 10.4% to 25.8%, and their revenue compound annual growth from FY22 to FY26 ranges from 8.3% to 42.2%.
Why do lending software, health services and IT stocks have a strong future roadmap in India?
Ans. Lending software, health services and IT stocks have a strong roadmap in India because banks upgrading their systems, healthcare organisations adopting digital tools and wider use of data and cloud keep widening the market for these technology companies. The main drivers are as follows. Bank systems. Lenders replace older platforms. Healthcare data. Providers adopt digital and AI tools. Cloud work. Clients move more work to platforms. Together these factors give the companies on this list a visible path for growth over the coming years.
How has Nucleus Software Exports performed financially?
Ans. Revenue rose from Rs 532 crore in FY22 to Rs 940 crore in FY26, a compound annual growth rate of 15.3%. Net profit grew from Rs 40.9 crore in FY22 to Rs 117 crore in FY26, which works out to a compound annual growth rate of 30.0%. The company has a return on equity of 14.7%, a debt to equity ratio of 0.01 and a market capitalisation of Rs 1,731 crore. The stock trades at a P/E of 16.4, below the industry P/E of 17.5. Looking ahead, the company is moving customers to cloud-based and subscription offerings, which build recurring revenue over time. Banks upgrading lending and transaction systems create steady demand for its platforms.
How has Inventurus Knowledge Solutions performed financially?
Ans. Revenue rose from Rs 784 crore in FY22 to Rs 3,211 crore in FY26, a compound annual growth rate of 42.2%. Net profit grew from Rs 233 crore in FY22 to Rs 722 crore in FY26, which works out to a compound annual growth rate of 32.7%. In the June 2026 quarter, revenue grew 21.0% year on year to Rs 899 crore, while net profit rose 27.8% to Rs 194 crore. The company has a return on equity of 25.8%, a debt to equity ratio of 0.27 and a market capitalisation of Rs 29,242 crore. The stock trades at a P/E of 38.3, above the industry P/E of 17.6. Looking ahead, the company is widening its technology-led services for risk adjustment, care coordination and revenue cycle work. Long-term relationships with large healthcare organisations give it recurring demand.
How has Mindteck (India) performed financially?
Ans. Revenue rose from Rs 304 crore in FY22 to Rs 417 crore in FY26, a compound annual growth rate of 8.3%. Net profit grew from Rs 20.8 crore in FY23 to Rs 31.5 crore in FY26, which works out to a compound annual growth rate of 14.9%. In the June 2026 quarter, revenue grew 2.8% year on year to Rs 107 crore. The company has a return on equity of 10.4%, a debt to equity ratio of 0.01 and a market capitalisation of Rs 436 crore. The stock trades at a P/E of 14.0, below the industry P/E of 17.6. Looking ahead, the company is focusing on digital engineering, data and cloud services for existing clients and widening its work in specialised industries. Long client relationships support steady project flow.
What risks should investors check before buying lending software, health services and IT stocks?
Ans. Investors should check a few risks before buying lending software, health services and IT stocks. Client spending. Technology budgets can vary with global conditions. Currency moves. Export earnings move with the rupee. Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.
Is this list of lending software, health services and IT stocks investment advice?
Ans. No. This article is educational and uses publicly available data as of the 29 October 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.
